Table 1 the baseline characteristics of participants
Variables | Cranberry group (n = 46) | Placebo group (n = 48) | p-value * |
|---|---|---|---|
Age (years) | 43.20 ± 11.30 | 43.13 ± 10.98 | 0.97 |
Sex n (%) male/female | 22 (47.8)/ 24 (52.2) | 23 (47.9)/ 25 (52.1) | 0.99 |
BMI (kg/m2) | 28.17 ± 4.99 | 28.63 ± 4.15 | 0.63 |
SBP (mmHg) | 127.39 ± 24.61 | 124.85 ± 23.20 | 0.60 |
DBP (mmHg) | 79.35 ± 10.19 | 77.90 ± 9.05 | 0.46 |
Total cholesterol (mg/dL) | 209.8 ± 64.13 | 205.60 ± 50.16 | 0.72 |
LDL-C (mg/dL) | 144.13 ± 20.62 | 143.27 ± 20.02 | 0.83 |
HDL-C (mg/dL) | 33.67 ± 4.21 | 34.46 ± 5.00 | 0.41 |
TG (mg/dL) | 198.9 ± 64.99 | 181.50 ± 57.79 | 0.17 |
AST (IU/L) | 37.22 ± 13.51 | 41.17 ± 16.69 | 0.21 |
ALT (IU/L) | 42.74 ± 15.04 | 47.48 ± 18.35 | 0.17 |
ALP (IU/L) | 251.57 ± 32.89 | 248.08 ± 27.18 | 0.57 |
FBS (mg/dL) | 105.22 ± 9.04 | 105.81 ± 9.08 | 0.75 |
Insulin (μ/mL) | 10.38 ± 3.09 | 10.65 ± 3.02 | 0.67 |
HOMA-IR | 2.78 ± 0.99 | 2.84 ± 0.98 | 0.74 |
Steatosis grade n (%) | |||
Grade 1 | 13 (28.3) | 16 (33.3) | 0.8** |
Grade 2 | 28 (60.9) | 26 (54.2) | |
Grade 3 | 5 (10.9) | 6 (12.5) | |